Can Ultrasound Guide Treatment Decisions in Difficult‐to‐Treat Rheumatoid Arthritis?
Open Access
- 29 October 2026
- journal article
- Published by Wiley in Arthritis & Rheumatology
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A global OMERACT ultrasound joint damage scoring system (GLODS) in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2026
- Synovial biopsy and tissue sampling in the management of RARheumatology, 2026
- Predicting rapid radiographic progression in difficult-to-treat rheumatoid arthritis: insights from long-term follow-upRheumatology, 2025
- Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritisAnnals of the Rheumatic Diseases, 2025
- Neither ultrasound synovitis nor clinical-ultrasound phenotypes of established rheumatoid arthritis predict response to targeted therapyRheumatology, 2025
- The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature reviewAutoimmunity Reviews, 2024
- Poly‐Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory PhenotypesArthritis & Rheumatology, 2024
- Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trialsThe Lancet Rheumatology, 2023
- Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialThe Lancet, 2021
- Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritisNature Reviews Rheumatology, 2020